Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
Jeffrey S. Barrett(Aridhia (United Kingdom)), M. Turner(University of Liverpool), William Roddy(Critical Path Institute), Bernard Thébaud(Children's Hospital of Eastern Ontario), Klaus Romero(Critical Path Institute), Jack M. H. Beusmans(Metrum Research Group (United States)), Megan Cala Pane(Critical Path Institute), Timothy J. Knab(Metrum Research Group (United States)), Michael Padula(Children's Hospital of Philadelphia), Jonathan Michael Davis(Tufts Medical Center), Kanwaljit Singh(Critical Path Institute), Eric Jordie(Metrum Research Group (United States))
Cited by 5
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Delivery Room Management of the Apparently Vigorous Meconium-stained Neonate: Results of the Multicenter, International Collaborative Trial
|PEDIATRICS|2000|735
Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension
|Circulation|2010|409
Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage
|Nature Communications|2021|218
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year
|The Journal of Pediatrics|2018|151